Viveka Roychowdhury 226 posts 3 comments

Primed with experience from their stints in bluechip research-driven companies like Piramal Lifesciences and GE Healthcare, two…

India's abysmal doctor/nurse-patient ratio is set to get worse as the toll of COVID-19 positive healthcare workers rise. However,…

As hospitals start setting up temporary isolation facilities for COVID-19 positive patients, the DRI - Pahwa Group has received…

While promoting hygiene through its products made up of waterless technology, Clensta International has created the first line of…

A week into the 21 day lock down, are we more confident of confronting the coronavirus?  


Jason Dehni, Regional President Asia Pacific, Solve.Care in an interaction with Viveka Roychowdhury talks about the measures that…

India's policymakers will have to tread a fine line between collaboration and compromise. Coordination and collaboration between…

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint…

Addressing the dearth of accredited laboratories in India, some established players are undertaking capacity building initiatives.…

Mary Rodgers, ‘virus hunter’, Principal Scientist and Head, Abbott Global Surveillance Center explains to Viveka Roychowdhury the…